CO4990943A1 - Nuevo producto farmaceutico -n-(2-piridil)amino)etoxi]bencil]tiazolidin-2-4-diona - Google Patents
Nuevo producto farmaceutico -n-(2-piridil)amino)etoxi]bencil]tiazolidin-2-4-dionaInfo
- Publication number
- CO4990943A1 CO4990943A1 CO98074832A CO98074832A CO4990943A1 CO 4990943 A1 CO4990943 A1 CO 4990943A1 CO 98074832 A CO98074832 A CO 98074832A CO 98074832 A CO98074832 A CO 98074832A CO 4990943 A1 CO4990943 A1 CO 4990943A1
- Authority
- CO
- Colombia
- Prior art keywords
- provides
- amino
- tiazolidin
- piridil
- etoxi
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Un hidrato de la sal de ácido maleico de 5-[4-[2-(N-metil-N-(2-piridil)amino)etoxi]bencil]tiazolidina-2,4-diona, caracterizado porque: (i) comprende agua en el intervalo de 0,3 a 0,6 equivalentes molares; y (ii) proporciona un espectro infrarrojo que contiene picos a 1757, 1331, 1290, 1211 y 767 cm-1 ; y/o (iii) proporciona un espectro Raman que contiene picos a 1758, 1610, 1394, 1316 1289 cm-1 ; y/o (iv) proporciona un espectro de resonancia magnética nuclear en estado sólido que contiene desplazamientos químicos sustancialmente como se indica en la Tabla I; y/o (v) proporciona una imagen de difracción en polvo de rayos X (XRPD) sustancialmente como se indica en la Figura IV. Tabla I Desplazamientos químicos 13C del Hidrato Desplazamiento químico (ppm) 32,4 59,3 117,6 152,8 177,538,8 65,6 119,8 154,9 179,242,1 67,0 133,1 159,442,9 68,4 135,2 160,243,8 111,5 138,5 168,153,0 113,8 139,9 171,354,7 115,3 148,5 174,457,2 116,4 149,0 175,0
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726563.1A GB9726563D0 (en) | 1997-12-16 | 1997-12-16 | Novel pharmaceutical |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4990943A1 true CO4990943A1 (es) | 2000-12-26 |
Family
ID=10823691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98074832A CO4990943A1 (es) | 1997-12-16 | 1998-12-16 | Nuevo producto farmaceutico -n-(2-piridil)amino)etoxi]bencil]tiazolidin-2-4-diona |
Country Status (37)
| Country | Link |
|---|---|
| US (4) | US20020133016A1 (es) |
| EP (1) | EP1042321A1 (es) |
| JP (1) | JP2002508371A (es) |
| KR (1) | KR100549141B1 (es) |
| CN (3) | CN101318957A (es) |
| AP (1) | AP1363A (es) |
| AR (2) | AR017211A1 (es) |
| AU (2) | AU2272299A (es) |
| BG (1) | BG64850B1 (es) |
| BR (1) | BR9813598A (es) |
| CA (1) | CA2314967A1 (es) |
| CO (1) | CO4990943A1 (es) |
| CZ (1) | CZ300081B6 (es) |
| DZ (1) | DZ2679A1 (es) |
| EA (1) | EA002833B1 (es) |
| EG (1) | EG22250A (es) |
| GB (1) | GB9726563D0 (es) |
| HR (1) | HRP20000404A2 (es) |
| HU (1) | HUP0102292A3 (es) |
| ID (1) | ID24714A (es) |
| IL (2) | IL160847A0 (es) |
| MA (1) | MA26581A1 (es) |
| MY (1) | MY128573A (es) |
| NO (1) | NO317255B1 (es) |
| NZ (1) | NZ504703A (es) |
| OA (1) | OA11900A (es) |
| PE (1) | PE20000125A1 (es) |
| PL (1) | PL341213A1 (es) |
| RS (1) | RS50080B (es) |
| SA (1) | SA99200200B1 (es) |
| SK (1) | SK286422B6 (es) |
| TR (2) | TR200001793T2 (es) |
| TW (1) | TW487709B (es) |
| UA (1) | UA66821C2 (es) |
| UY (2) | UY25309A1 (es) |
| WO (1) | WO1999031093A1 (es) |
| ZA (1) | ZA9811504B (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| GB9726568D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| GB9909041D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Plc | Novel pharmaceutical |
| KR100744359B1 (ko) * | 1999-04-23 | 2007-07-30 | 스미스클라인비이참피이엘시이 | 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도 |
| TR200103060T2 (tr) * | 1999-04-23 | 2002-05-21 | Smithkline Beecham P. L. C. | Yeni farmasötik maddeler |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| ATE246191T1 (de) | 1999-04-23 | 2003-08-15 | Smithkline Beecham Plc | Polymorph von 5-(4-(2-(n-methyl-n-(2- pyrdyl)amino)äthoxy)benzyl)thiazolidin-2,4-dion maleinsäuresalz |
| GB0014005D0 (en) * | 2000-06-08 | 2000-08-02 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021784D0 (en) * | 2000-09-05 | 2000-10-18 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0021978D0 (en) * | 2000-09-07 | 2000-10-25 | Smithkline Beecham Plc | Novel pharmaceutical |
| GB0129876D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
| WO2003050112A1 (en) * | 2001-12-13 | 2003-06-19 | Smithkline Beecham Plc | Toluenesulfonate hydrates of a thiazolidinedione derivative |
| KR100450700B1 (ko) * | 2002-03-22 | 2004-10-01 | 주식회사종근당 | 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물 |
| EP1468997A3 (en) * | 2003-04-18 | 2004-11-03 | CHEMI S.p.A. | Polymorphous forms of rosiglitazone maleate |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| US20050163842A1 (en) * | 2003-12-31 | 2005-07-28 | Garth Boehm | Rosiglitazone and metformin formulations |
| WO2005065654A2 (en) * | 2003-12-31 | 2005-07-21 | Alpharma, Inc. | Rosiglitazone formulations |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| US7435741B2 (en) * | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
| EP2184055A1 (en) | 2008-11-07 | 2010-05-12 | LEK Pharmaceuticals d.d. | Process for preparing solid dosage forms of rosiglitazone maleate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3856378T2 (de) | 1987-09-04 | 2000-05-11 | Beecham Group Plc | Substituierte Thiazolidindionderivate |
| US6288095B1 (en) | 1987-09-04 | 2001-09-11 | Beecham Group P.L.C. | Compounds |
| GB8820389D0 (en) * | 1988-08-26 | 1988-09-28 | Beecham Group Plc | Novel compounds |
| GB9124513D0 (en) * | 1991-11-19 | 1992-01-08 | Smithkline Beecham Plc | Novel process |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US5741803A (en) | 1992-09-05 | 1998-04-21 | Smithkline Beecham Plc | Substituted thiazolidinedionle derivatives |
| SG47100A1 (en) * | 1994-02-10 | 1998-03-20 | Smithkline Beecham Plc | Use of insulin sensitisers for treating renal diseases |
| DE4404198A1 (de) | 1994-02-10 | 1995-08-17 | Henkel Kgaa | 2-Fluor-6-nitroaniline |
| US6664278B2 (en) | 1997-12-16 | 2003-12-16 | Smithkline Beecham P.L.C. | Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt |
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| CA2426117A1 (en) | 2000-09-26 | 2002-04-04 | Dr. Reddy's Research Foundation | Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation |
-
1997
- 1997-12-16 GB GBGB9726563.1A patent/GB9726563D0/en not_active Ceased
-
1998
- 1998-12-14 AU AU22722/99A patent/AU2272299A/en not_active Abandoned
- 1998-12-14 ID IDW20001128A patent/ID24714A/id unknown
- 1998-12-14 CN CNA2008100919932A patent/CN101318957A/zh active Pending
- 1998-12-14 MA MA25391A patent/MA26581A1/fr unknown
- 1998-12-14 BR BR9813598-8A patent/BR9813598A/pt not_active Application Discontinuation
- 1998-12-14 UA UA2000063483A patent/UA66821C2/uk unknown
- 1998-12-14 CA CA002314967A patent/CA2314967A1/en not_active Abandoned
- 1998-12-14 PL PL98341213A patent/PL341213A1/xx not_active Application Discontinuation
- 1998-12-14 EP EP98966320A patent/EP1042321A1/en not_active Withdrawn
- 1998-12-14 JP JP2000539017A patent/JP2002508371A/ja not_active Withdrawn
- 1998-12-14 WO PCT/EP1998/008153 patent/WO1999031093A1/en active IP Right Grant
- 1998-12-14 AP APAP/P/2000/001829A patent/AP1363A/en active
- 1998-12-14 CZ CZ20002206A patent/CZ300081B6/cs not_active IP Right Cessation
- 1998-12-14 KR KR1020007006514A patent/KR100549141B1/ko not_active IP Right Cessation
- 1998-12-14 IL IL16084798A patent/IL160847A0/xx unknown
- 1998-12-14 RS YUP-364/00A patent/RS50080B/sr unknown
- 1998-12-14 IL IL13642598A patent/IL136425A/en unknown
- 1998-12-14 TR TR2000/01793T patent/TR200001793T2/xx unknown
- 1998-12-14 HU HU0102292A patent/HUP0102292A3/hu unknown
- 1998-12-14 OA OA00000177A patent/OA11900A/en unknown
- 1998-12-14 NZ NZ504703A patent/NZ504703A/xx unknown
- 1998-12-14 CN CNA2008100919928A patent/CN101318956A/zh active Pending
- 1998-12-14 CN CN98812091A patent/CN1285831A/zh active Pending
- 1998-12-14 SK SK918-2000A patent/SK286422B6/sk not_active IP Right Cessation
- 1998-12-14 EA EA200000656A patent/EA002833B1/ru not_active IP Right Cessation
- 1998-12-15 AR ARP980106364A patent/AR017211A1/es unknown
- 1998-12-15 UY UY25309A patent/UY25309A1/es not_active IP Right Cessation
- 1998-12-15 ZA ZA9811504A patent/ZA9811504B/xx unknown
- 1998-12-15 AR ARP980106368A patent/AR016161A1/es not_active Application Discontinuation
- 1998-12-15 MY MYPI98005673A patent/MY128573A/en unknown
- 1998-12-15 UY UY25306A patent/UY25306A1/es unknown
- 1998-12-15 EG EG155398A patent/EG22250A/xx active
- 1998-12-15 DZ DZ980289A patent/DZ2679A1/xx active
- 1998-12-16 TR TR1998/02624A patent/TR199802624A2/xx unknown
- 1998-12-16 TW TW087121120A patent/TW487709B/zh not_active IP Right Cessation
- 1998-12-16 PE PE1998001231A patent/PE20000125A1/es not_active Application Discontinuation
- 1998-12-16 CO CO98074832A patent/CO4990943A1/es unknown
-
1999
- 1999-05-31 SA SA99200200A patent/SA99200200B1/ar unknown
-
2000
- 2000-06-15 NO NO20003070A patent/NO317255B1/no not_active IP Right Cessation
- 2000-06-16 HR HR20000404A patent/HRP20000404A2/hr not_active Application Discontinuation
- 2000-07-13 BG BG104606A patent/BG64850B1/bg unknown
-
2002
- 2002-02-08 US US10/071,339 patent/US20020133016A1/en not_active Abandoned
- 2002-03-20 AU AU27538/02A patent/AU770818B2/en not_active Ceased
-
2003
- 2003-01-30 US US10/354,365 patent/US20030139604A1/en not_active Abandoned
-
2005
- 2005-08-17 US US11/205,426 patent/US20050288513A1/en not_active Abandoned
-
2006
- 2006-09-28 US US11/536,313 patent/US7368574B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4990943A1 (es) | Nuevo producto farmaceutico -n-(2-piridil)amino)etoxi]bencil]tiazolidin-2-4-diona | |
| CO4980880A1 (es) | Hidrato novedoso n-(2-piridil)amino)etoxi]etoxi]bencil]tiazolidin-2-4-diona | |
| CO5170421A1 (es) | Nuevo compuesto farmaceutico maleico | |
| HUP0300158A2 (en) | Hydrochloride salts of-5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, method for their production and pharmaceutical compositions containing them | |
| UY26120A1 (es) | Nuevo compuesto farmacéutico art 127 de la ley 17164 | |
| CO4990927A1 (es) | Nuevo producto farmaceutico -n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona | |
| AP1607A (en) | Thiazolidinedione derivative and its use as antidiabetic. | |
| ES2076894A1 (es) | Derivados de 2-(4-(4-azolibutil)-1-piperacinil)-5-hidroxipirimidina, su preparacion y su aplicacion como medicamentos. | |
| AP1562A (en) | Thiazolidinedione derivatives and its use as antidiabetic. | |
| CO5170420A1 (es) | Nuevos farmacos hidrocloruro | |
| ECSP982781A (es) | Hidrato de la sal de maleico de 5-[4- (-n -metil-n- (2-piridil) amino) etoxi) bensil) tiazolidina - 2,4 diona | |
| ECSP982780A (es) | Nuevo producto farmaceutico proceso para su preparacion y su uso en medicina | |
| ECSP982779A (es) | Un hidrato de la sal de acido maleico, proceso para la preparacion, composicion farmaceutica y su uso en medicina | |
| ECSP003438A (es) | Nuevos compuestos | |
| ECSP003436A (es) | Nuevos compuestos | |
| ECSP003434A (es) | Nuevos compuestos | |
| AR017867A1 (es) | Un hidrato de la sal del acido maleico de 5-4-2-(n-metil-n(2-piridil)amino)etoxi bencil tiazolidin-2,4-diona, un proceso para su preparacion, una composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento. |